|
Diagnosis and Management of HBV in Managed Care
Post Test
A score of 70% must be achieved to receive continuing education
credits.
|
| 1. |
HBV is classified into ____ genotypes.
a.
5
b.
7
c.
9
d.
11 |
| 2. |
Hepatitis B kills _______ to
______ persons each year.
a.250,000
– 500,000
b.300,000
– 550,000
c.500,000 – 750,000
d.750,000 – 1,000,000 |
| 3. |
About ____ % of persons have no signs or symptoms.
a.
25
b.
30
c.
35
d. 50 |
| 4. |
Symptoms can include:
a.
Fatigue
b. Abdominal
Pain
c.
Nausea, vomiting
d.
All of the above |
| 5. |
Who should
be vaccinated for Hepatitis B?
a.
All babies, at birth
b.
All children 1 – 18 years of age who have not been vaccinated
c.
People of any age whose behavior or job puts them at high risk for
HBV infection
d.
All of the above |
| 6. |
What are the types of vaccinations for Hepatitis A and B?
a.
Monovalent
b.
Bivalent
c.
Both A & B
d.
None of the above |
| 7 |
In oral mono-therapy,
emerging data revealing that patients without substantial early
viral suppression are less likely to develop resistance.
True
False |
| 8 |
Who are candidates for Combination Therapy?
a.
Advanced cirrhosis
b.
Less advanced cirrhosis
c.
Patients in whom long-term therapy is anticipated
d.
All of the above |
| 9 |
The role of combination therapy may be
more effective than monotherapy in suppressing viral replication.
True
False |
| 10 |
The role of combination therapy may
increase the incidence of drug resistance.
True
False |
|
Activity
Evaluation
Please rate this activity on the following
scale:
4 - Excellent 3 - Good
2 - Fair 1 - Poor |
|
|
|
Due to the content of this activity, I
will change my practice patterns by:
Continuing education implies quality improvement in
behavior. As part of our quality improvement process, NAMCP/AAMCN
will contact you 6 months from your post test submission to monitor
change.
|
|
|